Imatinib mesylate-induced acute hepatitis with autoimmune features. 2006

Valérie Dhalluin-Venier, and Caroline Besson, and Stéphanie Dimet, and Anne Thirot-Bibault, and Gilbert Tchernia, and Catherine Buffet
Hepatogastroenterology, Bicêtre Hospital, LeKremlin Bicêtre, France. Valerie.dhalluin@bct.ap-hop-paris.fr

Autoimmune hepatitis is a disorder of unknown aetiology. Imatinib belongs to a new class of anticancer agents with high selectivity toward a specific molecular target. Its main indications are chronic myeloid leukaemia and gastrointestinal tumours. We report here, for the first time to our knowledge, imatinib mesylate-induced hepatitis with autoimmune features.

UI MeSH Term Description Entries
D008111 Liver Function Tests Blood tests that are used to evaluate how well a patient's liver is working and also to help diagnose liver conditions. Function Test, Liver,Function Tests, Liver,Liver Function Test,Test, Liver Function,Tests, Liver Function
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D011092 Polyethylene Glycols Polymers of ETHYLENE OXIDE and water, and their ethers. They vary in consistency from liquid to solid depending on the molecular weight indicated by a number following the name. They are used as SURFACTANTS, dispersing agents, solvents, ointment and suppository bases, vehicles, and tablet excipients. Some specific groups are NONOXYNOLS, OCTOXYNOLS, and POLOXAMERS. Macrogols,Polyoxyethylenes,Carbowax,Macrogol,Polyethylene Glycol,Polyethylene Oxide,Polyethyleneoxide,Polyglycol,Glycol, Polyethylene,Glycols, Polyethylene,Oxide, Polyethylene,Oxides, Polyethylene,Polyethylene Oxides,Polyethyleneoxides,Polyglycols,Polyoxyethylene
D011241 Prednisone A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. Dehydrocortisone,delta-Cortisone,Apo-Prednisone,Cortan,Cortancyl,Cutason,Dacortin,Decortin,Decortisyl,Deltasone,Encorton,Encortone,Enkortolon,Kortancyl,Liquid Pred,Meticorten,Orasone,Panafcort,Panasol,Predni Tablinen,Prednidib,Predniment,Prednison Acsis,Prednison Galen,Prednison Hexal,Pronisone,Rectodelt,Sone,Sterapred,Ultracorten,Winpred,Acsis, Prednison
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000068877 Imatinib Mesylate A tyrosine kinase inhibitor and ANTINEOPLASTIC AGENT that inhibits the BCR-ABL kinase created by chromosome rearrangements in CHRONIC MYELOID LEUKEMIA and ACUTE LYMPHOBLASTIC LEUKEMIA, as well as PDG-derived tyrosine kinases that are overexpressed in gastrointestinal stromal tumors. Alpha-(4-methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-p-tolu-p-toluidide,CGP 57148,CGP-57148,CGP57148B,Gleevec,Glivec,Imatinib,Imatinib Methanesulfonate,ST 1571,ST1571,STI 571,STI-571,STI571,CGP57148,Mesylate, Imatinib,Methanesulfonate, Imatinib

Related Publications

Valérie Dhalluin-Venier, and Caroline Besson, and Stéphanie Dimet, and Anne Thirot-Bibault, and Gilbert Tchernia, and Catherine Buffet
October 2004, Gastroenterologie clinique et biologique,
Valérie Dhalluin-Venier, and Caroline Besson, and Stéphanie Dimet, and Anne Thirot-Bibault, and Gilbert Tchernia, and Catherine Buffet
May 2003, Leukemia,
Valérie Dhalluin-Venier, and Caroline Besson, and Stéphanie Dimet, and Anne Thirot-Bibault, and Gilbert Tchernia, and Catherine Buffet
December 2023, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners,
Valérie Dhalluin-Venier, and Caroline Besson, and Stéphanie Dimet, and Anne Thirot-Bibault, and Gilbert Tchernia, and Catherine Buffet
March 2008, European journal of internal medicine,
Valérie Dhalluin-Venier, and Caroline Besson, and Stéphanie Dimet, and Anne Thirot-Bibault, and Gilbert Tchernia, and Catherine Buffet
July 2006, European journal of gastroenterology & hepatology,
Valérie Dhalluin-Venier, and Caroline Besson, and Stéphanie Dimet, and Anne Thirot-Bibault, and Gilbert Tchernia, and Catherine Buffet
January 2012, Indian journal of dermatology, venereology and leprology,
Valérie Dhalluin-Venier, and Caroline Besson, and Stéphanie Dimet, and Anne Thirot-Bibault, and Gilbert Tchernia, and Catherine Buffet
December 2018, The Journal of the Association of Physicians of India,
Valérie Dhalluin-Venier, and Caroline Besson, and Stéphanie Dimet, and Anne Thirot-Bibault, and Gilbert Tchernia, and Catherine Buffet
July 2010, Journal of the American Academy of Dermatology,
Valérie Dhalluin-Venier, and Caroline Besson, and Stéphanie Dimet, and Anne Thirot-Bibault, and Gilbert Tchernia, and Catherine Buffet
November 2007, Leukemia & lymphoma,
Valérie Dhalluin-Venier, and Caroline Besson, and Stéphanie Dimet, and Anne Thirot-Bibault, and Gilbert Tchernia, and Catherine Buffet
July 2007, The Journal of the Association of Physicians of India,
Copied contents to your clipboard!